Forte Biosciences, Inc. Quarterly Return On Equity in % from Q3 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Forte Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2017 to Q3 2024.
  • Forte Biosciences, Inc. Return On Equity for the quarter ending September 30, 2024 was -151 %, a 70.2% decline year-over-year.
  • Forte Biosciences, Inc. annual Return On Equity for 2023 was -94.3 %, a 172% decline from 2022.
  • Forte Biosciences, Inc. annual Return On Equity for 2022 was -34.7 %, a 24.1% increase from 2021.
  • Forte Biosciences, Inc. annual Return On Equity for 2021 was -45.8 %, a 76% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -151 -62.5 -70.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -118 -49.2 -71.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -99.4 -52.2 -110% Jan 1, 2024 Mar 31, 2024
Q4 2023 -94.3 -59.6 -172% Oct 1, 2023 Dec 31, 2023
Q3 2023 -89 -58.6 -193% Jul 1, 2023 Sep 30, 2023
Q2 2023 -68.6 -27.8 -68% Apr 1, 2023 Jun 30, 2023
Q1 2023 -47.3 -2.82 -6.34% Jan 1, 2023 Mar 31, 2023
Q4 2022 -34.7 +11 +24.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -30.4 +13.9 +31.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -40.9 +3.28 +7.43% Apr 1, 2022 Jun 30, 2022
Q1 2022 -44.5 +79.5 +64.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -45.8 +145 +76% Oct 1, 2021 Dec 31, 2021
Q3 2021 -44.3 +580 +92.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -44.1 +1.86K +97.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -124 -446 -138% Jan 1, 2021 Mar 31, 2021
Q4 2020 -191 -611 -145% Oct 1, 2020 Dec 31, 2020
Q3 2020 -624 -1.67K -160% Jul 1, 2020 Sep 30, 2020
Q2 2020 -1.9K -1.7K -827% Apr 1, 2020 Jun 30, 2020
Q1 2020 322 +486 Jan 1, 2020 Mar 31, 2020
Q4 2019 420 +548 Oct 1, 2019 Dec 31, 2019
Q3 2019 1.05K +1.12K Jul 1, 2019 Sep 30, 2019
Q2 2019 -205 -128 -165% Apr 1, 2019 Jun 30, 2019
Q1 2019 -164 -107 -187% Jan 1, 2019 Mar 31, 2019
Q4 2018 -128 +17.5 +12% Oct 1, 2018 Dec 31, 2018
Q3 2018 -71.6 -236 -143% Jul 1, 2018 Sep 30, 2018
Q2 2018 -77.5 Apr 1, 2018 Jun 30, 2018
Q1 2018 -57.1 Jan 1, 2018 Mar 31, 2018
Q4 2017 -146 Oct 1, 2017 Dec 31, 2017
Q3 2017 165 Jul 1, 2017 Sep 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.